SCHEMBL16837829

SCHEMBL16837829

CC(C)c1ccc2ccc(Br)cc2n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 2/20 0.52
▸ HTT P42858 3/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ CYP2A6 P11509 1/20 0.40
▸ LMNA P02545 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ RAB9A P51151 1/20 0.37
▸ PABPC1 P11940 1/20 0.36
▸ CYSLTR2 Q9NS75 1/20 0.35
▸ CYSLTR1 Q9Y271 1/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ METAP2 P50579 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25727243 0.86 BACE1 (0.53) BACE1HTTCYP1A2CYP2C19CYP2A6
SCHEMBL25293731 0.85 BACE1 (0.53) BACE1HTTCYP1A2CYP2C19CYP2A6
SCHEMBL18563600 0.85 BACE1 (0.48) BACE1HTTCYP1A2CYP2C19CYP2A6
SCHEMBL15443472 0.85 BACE1 (0.53) BACE1HTTCYP1A2CYP2C19CYP2A6
SCHEMBL15447479 0.85 BACE1 (0.48) BACE1HTTCYP1A2CYP2C19CYP2A6
SCHEMBL16837671 0.82 BACE1 (0.46) BACE1HTTCYP1A2CYP2C19CYP2A6
SCHEMBL2609305 0.78 NR4A2 (0.47) CYP1A2CYP2A6LMNASMN1; SMN2ALDH1A1
SCHEMBL10199294 0.78 NPC1 (0.41) HTTCYP1A2LMNASMN1; SMN2RAB9A
SCHEMBL17179438 0.78 CYP1A2 (0.57) BACE1CYP1A2CYP2A6LMNAALDH1A1
SCHEMBL28417141 0.76 BACE1 (0.61) BACE1HTTCYP1A2CYP2C19CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256419-A1 DUAL WNT SIGNALING PATHWAY INHIBITORS AND AMPK ACTIVATORS FOR TREATMENTS OF DISEASE UNIVERSITY OF MARYLAND, BALTIMORE (US) 2022-12-08 — — WO disclosed
EP-2861601-B1 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES GILEAD SCIENCES INC (US) 2018-02-07 — — EP disclosed
US-20170190734-A1 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES Selcia Ltd. (GB) 2017-07-06 — — US disclosed
US-9642889-B2 Macrocyclic inhibitors of Flaviviridae viruses GILEAD SCIENCES, INC. (US) 2017-05-09 — — US disclosed
US-20160220633-A1 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES CYPRALIS LIMITED (GB) 2016-08-04 — — US disclosed
US-20150361132-A1 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES CYPRALIS LIMITED (GB) 2015-12-17 — — US disclosed
US-9062092-B2 Macrocyclic inhibitors of Flaviviridae viruses GILEAD SCIENCES, INC. (US) 2015-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160220633-A1 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES HAVCR2, ZC3HAV1, HCCS BACE1 2938/4885HTT 4373/4885CYP1A2 107/4885
US-20170190734-A1 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES HAVCR2, ZC3HAV1, HCCS BACE1 2938/4885HTT 4373/4885CYP1A2 107/4885
US-20150361132-A1 MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES HAVCR2, ZC3HAV1, HCCS BACE1 2938/4885HTT 4373/4885CYP1A2 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback